Jubilant Ingrevia Ltd. (IN:JUBLINGREA)
:JUBLINGREA
Want to see IN:JUBLINGREA full AI Analyst Report?
JUBLINGREA Stock Chart & Stats
₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)
Day’s Range― - ―
52-Week Range₹535.30 - ₹851.85
Previous CloseN/A
Volume517.05K
Average Volume (3M)13.09K
Market Cap
₹117.65B
Enterprise Value₹123.45B
Total Cash (Recent Filing)₹469.10M
Total Debt (Recent Filing)₹8.06B
Price to Earnings (P/E)59.2
Beta0.92
Next Earnings
May 19, 2026EPS Estimate
4.35Next Dividend Ex-DateN/A
Dividend Yield0.74%
Share Statistics
EPS (TTM)3.60
Shares Outstanding159,281,140
10 Day Avg. Volume10,350
30 Day Avg. Volume13,091
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.53
Price to Sales (P/S)2.51
P/FCF Ratio72.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.74
Revenue Forecast (FY)₹50.97B
Bulls Say, Bears Say
Bulls Say
Stable Profit MarginsSustained gross, EBIT and EBITDA margin stability indicates durable operating efficiency and pricing power across product lines. This supports predictable operating cash flow, enables reinvestment in capacity and R&D, and underpins resilience across 2–6 month horizons and beyond.
Improved Cash GenerationA move to consistently positive free cash flow and strong operating cash conversion enhances financial flexibility. Durable cash generation allows funding of capex, debt servicing and working capital without reliance on external financing, supporting long-term investment and stability.
Integrated Manufacturing And Diversified B2B PortfolioVertical integration across fermentation and chemical synthesis plus diversified end-markets (pharma, nutrition, agro) create cost efficiencies, supply reliability and cross-selling opportunities. These structural strengths support durable customer relationships and stable recurring B2B revenues.
Bears Say
Revenue Volatility And Recent DipIntermittent revenue declines increase forecasting uncertainty and can strain margins, working capital and customer contracts. If demand or pricing pressure recurs, investment plans and margin targets could be deferred, reducing operational predictability over the medium term.
Rising Total Liabilities / Moderate LeverageGrowing liabilities and moderate leverage reduce financial flexibility and increase sensitivity to higher interest rates or cyclical revenue shortfalls. This constrains ability to pursue inorganic growth or weather downturns without increasing funding costs or cutting discretionary spending.
Prior Negative Free Cash Flow PeriodsHistorical episodes of negative free cash flow indicate periodic mismatches between capex and cash generation. Recurrence could force external financing or reduce strategic optionality, pressuring margins and limiting ability to fund new capacity or return capital to shareholders.
Jubilant Ingrevia Ltd. News
JUBLINGREA FAQ
What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹851.85 in the past 12 months.
What is Jubilant Ingrevia Ltd.’s market cap?
Jubilant Ingrevia Ltd.’s market cap is ₹117.65B.
When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
Jubilant Ingrevia Ltd.’s upcoming earnings report date is May 19, 2026 which is in 20 days.
How were Jubilant Ingrevia Ltd.’s earnings last quarter?
Jubilant Ingrevia Ltd. released its earnings results on Feb 04, 2026. The company reported ₹3.6 earnings per share for the quarter, beating the consensus estimate of ₹3.5 by ₹0.1.
Is Jubilant Ingrevia Ltd. overvalued?
According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued.
Does Jubilant Ingrevia Ltd. pay dividends?
Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.74%. See more information on Jubilant Ingrevia Ltd. dividends here
What is Jubilant Ingrevia Ltd.’s EPS estimate?
Jubilant Ingrevia Ltd.’s EPS estimate is 4.35.
How many shares outstanding does Jubilant Ingrevia Ltd. have?
Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
Jubilant Ingrevia Ltd. reported an EPS of ₹3.6 in its last earnings report, beating expectations of ₹3.5. Following the earnings report the stock price went down -1.778%.
Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
Currently, no hedge funds are holding shares in IN:JUBLINGREA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Piramal Pharma Limited
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―